Keybank National Association OH Increases Stock Holdings in Sanofi $SNY

Keybank National Association OH boosted its stake in Sanofi (NASDAQ:SNY) by 91.2% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 27,809 shares of the company’s stock after acquiring an additional 13,265 shares during the quarter. Keybank National Association OH’s holdings in Sanofi were worth $1,340,000 as of its most recent filing with the SEC.

Several other large investors also recently bought and sold shares of the company. Flagship Harbor Advisors LLC acquired a new stake in Sanofi during the 4th quarter worth $25,000. Physician Wealth Advisors Inc. boosted its position in shares of Sanofi by 180.5% during the 1st quarter. Physician Wealth Advisors Inc. now owns 589 shares of the company’s stock valued at $28,000 after acquiring an additional 379 shares during the last quarter. Measured Wealth Private Client Group LLC acquired a new position in Sanofi in the third quarter valued at approximately $29,000. Palisade Asset Management LLC purchased a new position in Sanofi in the third quarter worth approximately $30,000. Finally, Fairway Wealth LLC acquired a new position in Sanofi in the first quarter valued at about $32,000. 14.03% of the stock is currently owned by hedge funds and other institutional investors.

Sanofi Stock Performance

SNY traded up $0.58 on Tuesday, hitting $43.19. 278,502 shares of the company traded hands, compared to its average volume of 3,650,400. Sanofi has a 12-month low of $40.89 and a 12-month high of $52.68. The company has a 50 day moving average of $43.59 and a 200-day moving average of $45.79. The company has a quick ratio of 0.22, a current ratio of 1.01 and a debt-to-equity ratio of 0.17. The stock has a market capitalization of $104.71 billion, a PE ratio of 12.06, a PEG ratio of 1.07 and a beta of 0.34.

Sanofi Increases Dividend

The business also recently declared an annual dividend, which was paid on Wednesday, June 3rd. Investors of record on Monday, May 4th were issued a dividend of $2.4225 per share. This is a boost from Sanofi’s previous annual dividend of $2.04. This represents a dividend yield of 559.0%. The ex-dividend date of this dividend was Monday, May 4th. Sanofi’s dividend payout ratio is 49.16%.

Analysts Set New Price Targets

A number of research analysts have commented on SNY shares. BNP Paribas Exane cut Sanofi from an “outperform” rating to a “neutral” rating and set a $50.00 price target on the stock. in a research note on Monday, April 20th. Citigroup reiterated a “neutral” rating on shares of Sanofi in a research note on Monday, April 13th. Sanford C. Bernstein upgraded Sanofi to a “strong-buy” rating in a report on Thursday, March 19th. Argus raised shares of Sanofi to a “strong-buy” rating in a research report on Monday, April 27th. Finally, Weiss Ratings raised Sanofi from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, May 13th. Two research analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating and ten have given a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $51.00.

About Sanofi

Sanofi (NASDAQ:SNY) is a multinational pharmaceutical company headquartered in France that researches, develops, manufactures and markets prescription medicines, vaccines and consumer healthcare products. The company operates across multiple therapeutic areas, including immunology, rare diseases, oncology, cardiovascular and metabolic diseases, and vaccines through its Sanofi Pasteur division. Sanofi sells products to hospitals, clinics, governments and retail pharmacies, with a broad global footprint and significant presence in Europe, North America and emerging markets.

Key commercial offerings include specialty biologics and established small-molecule medicines.